CATX Stock Analysis: Buy, Sell, or Hold?
CATX - Perspective Therapeutics, Inc.
$3.79
-0.47 (-11.03%)
▼
WAIT
LOW Confidence
Last Updated: January 30, 2026
Earnings: Mar 26, 2026
Get Alerted When CATX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
2 traders called CATX this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: CATX is 19.9% above fair value ($3.16). While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: CATX is 19.9% above fair value ($3.16). While momentum could continue, risk/reward favors waiting for a pullback.
In-depth Analysis How we analyze
Valuation Analysis: CATX is currently trading at $3.79, which is considered extended relative to its 30-day fair value range of $2.39 to $3.16.
Technical Outlook: Technically, CATX is in a downtrend. Immediate support is located at $2.25, while resistance sits at $6.16. Short-term momentum is weak, with the stock down 11.0% recently.
Market Sentiment: CATX has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $12.31 (+188.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, CATX is in a downtrend. Immediate support is located at $2.25, while resistance sits at $6.16. Short-term momentum is weak, with the stock down 11.0% recently.
Market Sentiment: CATX has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $12.31 (+188.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Fair Price Range
$2.39 -
$3.16
Company Quality Score
63/100
(BUY)
Volume Confirmation
MODERATE
Confidence Score
42.1%
Protect Your Profits
Holding CATX? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price significantly overextended (+19.9% above fair value)
- BULLISH: Strong technical setup (75/100)
- BEARISH: Downward momentum (-11.0%)
- BULLISH: Trading 188.9% below Wall St target ($12.31)
Fair Price Analysis
30-Day Fair Range
$2.39 -
$3.16
Current vs Fair Value
EXTENDED
Support & Resistance Levels
Support Level
$2.25
Resistance Level
$6.16
Current Trend
Downtrend
Fundamental Context
Forward P/E (Next Year Est.)
-3.14
Wall Street Target
$12.31
(+188.9%)
Revenue Growth (YoY)
-43.4%
Last updated: January 30, 2026 5:39 PM ET
Data refreshes hourly during market hours. Next update: 6:39 PM
Data refreshes hourly during market hours. Next update: 6:39 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CATX showing a specific setup today?
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$124 | 59 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
26 analysts |
$85 | 65 BUY |
|
ABT
Abbott Laboratories |
BUY
28 analysts |
$136 | 63 BUY |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$110 | 63 BUY |
|
PODD
Insulet Corporation |
STRONG BUY
23 analysts |
$374 | 54 HOLD |
Advanced CATX Option Strategies
Professional options setups generated by AI based on today's CATX price and gamma walls.
